Cardiol Therapeutics (CRDL) News Today $1.10 +0.03 (+2.31%) As of 10:29 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRDL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Cardiol Therapeutics Inc. (NASDAQ:CRDL) Short Interest Update5 hours ago | marketbeat.comCardiol Therapeutics (NASDAQ:CRDL) Trading Down 3.7% - Here's WhySeptember 10, 2025 | marketbeat.comHC Wainwright Analysts Increase Earnings Estimates for CRDLAugust 20, 2025 | marketbeat.comCardiol Therapeutics (NASDAQ:CRDL) Announces Earnings ResultsAugust 16, 2025 | marketbeat.comCardiol Therapeutics Reports Q2 2025 Financial Results Amid Rising LossesAugust 14, 2025 | tipranks.comFY2026 Earnings Forecast for CRDL Issued By Leede FinancialAugust 12, 2025 | marketbeat.comCardiol Therapeutics (CRDL) Projected to Post Earnings on MondayAugust 5, 2025 | marketbeat.comCardiol Therapeutics (NASDAQ:CRDL) Shares Down 8.5% - Here's What HappenedJuly 18, 2025 | marketbeat.comCardiol Therapeutics Inc. (NASDAQ:CRDL) Given Average Rating of "Buy" by BrokeragesJune 21, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for CRDL Q2 Earnings?June 4, 2025 | marketbeat.comCardiol Therapeutics Analyst RatingsJune 4, 2025 | benzinga.comCardiol Therapeutics Analyst RatingsJune 4, 2025 | benzinga.comHC Wainwright & Co. Initiates Coverage of Cardiol Therapeutics (CRDL) with Buy RecommendationJune 2, 2025 | msn.comCardiol Therapeutics (NASDAQ:CRDL) Coverage Initiated at HC WainwrightJune 2, 2025 | marketbeat.comCardiol Therapeutics Reports Q1 2025 Financial ResultsMay 27, 2025 | tipranks.com487,295 Shares in Cardiol Therapeutics Inc. (NASDAQ:CRDL) Bought by PVG Asset Management CorpMay 27, 2025 | marketbeat.comCardiol Therapeutics Reports Q1 2025 Financial ResultsMay 14, 2025 | tipranks.comCardiol Therapeutics Inc. (NASDAQ:CRDL) Given Consensus Rating of "Buy" by AnalystsMay 10, 2025 | marketbeat.comEnvestnet Asset Management Inc. Makes New Investment in Cardiol Therapeutics Inc. (NASDAQ:CRDL)May 8, 2025 | marketbeat.comAdvisorShares Investments LLC Lowers Position in Cardiol Therapeutics Inc. (NASDAQ:CRDL)May 1, 2025 | marketbeat.comResearch Analysts Offer Predictions for CRDL Q1 EarningsApril 20, 2025 | marketbeat.comCardiol Therapeutics starts phase III trial for heart drugApril 18, 2025 | uk.investing.comRoth MKM Sticks to Its Buy Rating for Cardiol Therapeutics (CRDL)April 18, 2025 | markets.businessinsider.comCardiol Therapeutics (NASDAQ:CRDL) Earns Buy Rating from HC WainwrightApril 18, 2025 | marketbeat.comCardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Consensus Rating of "Buy" from BrokeragesApril 15, 2025 | marketbeat.comCardiol Therapeutics Reports Increased Losses Amid Rising ExpensesApril 14, 2025 | tipranks.comWhat is HC Wainwright's Forecast for CRDL FY2025 Earnings?April 12, 2025 | marketbeat.comHC Wainwright Reiterates Buy Rating for Cardiol Therapeutics (NASDAQ:CRDL)April 9, 2025 | marketbeat.comWe're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn RateApril 2, 2025 | finance.yahoo.comCardiol Therapeutics (NASDAQ:CRDL) Releases Earnings Results, Beats Expectations By $0.01 EPSApril 1, 2025 | marketbeat.comCardiol Therapeutics (CRDL) Projected to Post Quarterly Earnings on MondayMarch 31, 2025 | marketbeat.comTejara Capital Ltd Buys 1,344,167 Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL)March 19, 2025 | marketbeat.comCardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Average Recommendation of "Buy" from BrokeragesMarch 19, 2025 | marketbeat.comShort Interest in Cardiol Therapeutics Inc. (NASDAQ:CRDL) Increases By 26.4%March 18, 2025 | marketbeat.comCardiol Therapeutics' (CRDL) Buy Rating Reiterated at HC WainwrightFebruary 24, 2025 | marketbeat.comCardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Average Rating of "Buy" from AnalystsFebruary 22, 2025 | marketbeat.comCardiol Therapeutics says study shows benefit of cannabidiol drug in treating heart failureFebruary 20, 2025 | proactiveinvestors.comCardiol Therapeutics: Bargain Stock Price With Share Price Appreciation CatalystsFebruary 19, 2025 | seekingalpha.comShort Interest in Cardiol Therapeutics Inc. (NASDAQ:CRDL) Drops By 8.3%February 18, 2025 | marketbeat.comRODMAN&RENSHAW Upgrades Cardiol Therapeutics (NASDAQ:CRDL) to Strong-BuyJanuary 29, 2025 | marketbeat.comCardiol Therapeutics initiated with a Buy at Rodman & RenshawJanuary 28, 2025 | markets.businessinsider.comRodman & Renshaw sets $7 target on Cardiol Therapeutics stockJanuary 28, 2025 | msn.comCardiol Therapeutics (NASDAQ:CRDL) Earns Buy Rating from Analysts at Rodman & RenshawJanuary 28, 2025 | marketbeat.comCardiol Therapeutics Inc. (NASDAQ:CRDL) Short Interest Up 12.4% in DecemberJanuary 1, 2025 | marketbeat.comHC Wainwright Has Positive Outlook for CRDL FY2024 EarningsDecember 20, 2024 | marketbeat.comPRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent PericarditisDecember 19, 2024 | globenewswire.comCardiol Therapeutics (NASDAQ:CRDL) Earns "Buy" Rating from HC WainwrightDecember 18, 2024 | marketbeat.com3 Penny Stocks Ready to Break Out in 2025Vuzix, GeoVox Labs, and Cardiol Therapeutics emerged as notable penny stocks late in 2024 for their potential to scale operations and launch new products.November 29, 2024 | marketbeat.comWhat is HC Wainwright's Forecast for CRDL FY2024 Earnings?November 22, 2024 | marketbeat.comEdward Nash Reaffirms Buy Rating for Cardiol Therapeutics: Positive Phase II Data and Strategic Future Trials Boost Market PotentialNovember 21, 2024 | markets.businessinsider.com Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRDL Media Mentions By Week CRDL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRDL News Sentiment▼0.480.63▲Average Medical News Sentiment CRDL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRDL Articles This Week▼21▲CRDL Articles Average Week Get the Latest News and Ratings for CRDL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cardiol Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies IMAB News UPXI News RCKT News ABEO News CGC News FDMT News ALT News ALDX News FHTX News LRMR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRDL) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRDL Stock Alerts